David Zacut - 18 Mar 2026 Form 3 Insider Report for Brainsway Ltd. (BWAY)

Role
Director
Signature
/s/ David Zacut
Issuer symbol
BWAY
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 16:05:17 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zacut David Director 16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, JERUSALEM, ISRAEL /s/ David Zacut 18 Mar 2026 0001956357

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BWAY Ordinary Shares 1,382,865 18 Mar 2026 Direct F1, F2
holding BWAY Ordinary Shares 363,545 18 Mar 2026 By Meromei Elran David 2003 Ltd. F1, F3
holding BWAY Ordinary Shares 45,058 18 Mar 2026 By Meromei Elran Ltd. F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BWAY Stock Options (right to buy) 18 Mar 2026 Ordinary Shares 25,000 Direct F1, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 This figure includes: (i) 1,370,365 ordinary shares held jointly by Dr. Zacut and his spouse, (ii) 6,250 ordinary shares, and (iii) unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.
F3 Meromei Elran David 2003 Ltd. is wholly owned by the Reporting Person, who serves as its sole director.
F4 Meromei Elran Ltd. is wholly owned by the Reporting Person, who serves as its sole director.
F5 Stock options were granted on March 5, 2024, with the remaining options to purchase 12,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.
F6 The exercise price is NIS 11.17 per share.